Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
This comprehensive resource covers product change evaluation, postmarket surveillance, audit/inspection compliance, and various other laws and regulations pertaining to maintaining a product on the market.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Regulatory News | 06 March 2015 | By Stewart Eisenhart
Content provided by Emergo, a medical device regulatory affairs and quality assurance consulting firm with offices worldwide.
ANVISA, Brazil’s medical device market regulatory agency, has published new requirements for conducting clinical testing of devices in the country.
The new regulation, RDC 10/2015 (link in Portuguese), establishes procedures and processes required to perform clinical testing, and also introduces clinical testing petitions that will need to be submitted to ANVISA in cases where such testing of Class III or IV devices or devices intended for diagnostic purposes will be required. (IVD devices are not included under the scope of RDC 10/2015.)
RDC 10/2105 adopts a clinical testing approach more harmonized with international standards and agencies, with a stronger focus on technical documentation submissions and good clinical practices. By implementing the new regulation, ANVISA is attempting to boost Brazil’s profile as a viable destination for medical device clinical testing activities.
Previous regulations now revoked by RDC 10/2015 include RDC 39/2008, RDC 36/2012 and certain clauses in RDC 81/2008.
Emergo’s office in Brasilia will provide further analysis of the new ANVISA clinical testing requirements in the near future. To learn more about Brazil's medical device registration and approval process, see our video overview of ANVISA registration requirements.
Original Post at Emergo
Tags: Emergo, Emergo Group